linkedin twitter facebook

sales@oxford-optronix.com • +44 1235 821803 

Pioneering instrumentation
for the bio-sciences sector

View in pop-up

OxyFlo™

Our single-channel laser-Doppler tissue blood flow monitor/perfusion monitoring

  • Uncompromised reliability in continuous tissue blood flow assessment
  • Ideally suited to measurements of changing tissue blood flow in acute experimental models

Request a Quote

View in pop-up

OxyFlo™ Pro
OxyFlo™ Pro XL

Our multi-channel laser-Doppler tissue blood flow monitors with integrated touch-screen 

  • Uncompromised reliability in continuous tissue blood flow assessment
  • Ideally suited to measurements of changing tissue blood flow in acute experimental models
  • Enhanced productivity & features

Request a Quote

“We have used OxyFlo probes for animal tumour studies and found them a great addition to the range of techniques that we use for studying the tumour microenvironment. The Oxford Optronix team is always extremely helpful, providing knowledgeable and thoughtful advice on every occasion. We will certainly carry on using them..”

Dr Gillian Tozer, School of Medicine and Biomedical Sciences, University of Sheffield, UK

  • Overview
  • Key Benefits
  • Rationale
  • Data Examples
  • Testimonials
  • Applications
  • Specifications
  • FAQ
  • Probes
  • Accessories

Overview

Our OxyFlo™ devices are laser Doppler blood flowmetry (LDF) monitors intended for monitoring of relative microvascular blood flow in tissues.

Most applications are concerned with monitoring the competence of regional (microvascular) blood supply in specialties such as peripheral vascular disorders, cerebral perfusion monitoring in models of stroke and brain injury, tumour perfusion monitoring / angiogenesis, blood flow in free flaps and pedicle flaps, wound healing, surgery, transplantation and more.

Oxford Optronix Ltd. was founded when its current CEO pioneered the transition of laser-Doppler flowmetry technology into a commercial product in the early 1990's. 

Oxford Optronix remains a pioneer in the development of LDF technology and continues to set unrivalled standards of reliability, robustness and sensitivity, with the OxyFlo™ brand now well-established the world over in biomedical ischaemia research.

With the launch of OxyFlo™ Pro in 2013, our third-generation LDF platform, we blend contemporary design, plug and play convenience and touch-screen operation to provide one of the most advanced and reliable blood flow monitors on the market. 

OxyFlo™ and OxyFlo™ Pro are intended for laboratory, industrial and research use only.
OxyFlo™ and OxyFlo™ Pro are NOT intended for use in human subjects/patients. 

Made in Britain